Krystal Biotech buy Cantor Fitzgerald
Start price
20.02.25
/
50%
€178.75
Target price
20.02.26
€205.35
Performance (%)
22.52%
End price
21.02.26
€219.00
Summary
This prediction ended on 21.02.26 with a price of €219.00. The prediction had a final performance of 22.52%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | 1.802% | 1.802% | 137.702% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $215.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Cantor_Fitzgerald for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€105.00
13.12.23
13.12.23
€166.84
13.12.24
13.12.24
47.38%
14.12.24
14.12.24
Krystal Biotech
Start price
Target price
Perf. (%)
€103.00
07.11.23
07.11.23
€149.84
07.11.24
07.11.24
75.83%
08.11.24
08.11.24